Novel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in...

Cell Death and Disease 2018 / 7 Vol. 9; Iss. 7

Novel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of Sorafenib on hepatocellular carcinoma cells

Zhang, Yingshi, Li, Dandan, Jiang, Qiyu, Cao, Shuang, Sun, Huiwei, Chai, Yantao, Li, Xiaojuan, Ren, Tianshu, Yang, Ruichuang, Feng, Fan, Li, Bo-an, Zhao, Qingchun
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
9
Language:
english
Journal:
Cell Death & Disease
DOI:
10.1038/s41419-018-0804-6
Date:
July, 2018
File:
PDF, 4.00 MB
english, 2018
Conversion to is in progress
Conversion to is failed